Article

Immune evasion by staphylococci.

Microbiology Department, Moyne Institute of Preventive Medicine, Trinity College, Dublin 2, Ireland.
Nature Reviews Microbiology (Impact Factor: 23.32). 01/2006; 3(12):948-58. DOI: 10.1038/nrmicro1289
Source: PubMed

ABSTRACT Staphylococcus aureus can cause superficial skin infections and, occasionally, deep-seated infections that entail spread through the blood stream. The organism expresses several factors that compromise the effectiveness of neutrophils and macrophages, the first line of defence against infection. S. aureus secretes proteins that inhibit complement activation and neutrophil chemotaxis or that lyse neutrophils, neutralizes antimicrobial defensin peptides, and its cell surface is modified to reduce their effectiveness. The organism can survive in phagosomes, express polysaccharides and proteins that inhibit opsonization by antibody and complement, and its cell wall is resistant to lysozyme. Furthermore, S. aureus expresses several types of superantigen that corrupt the normal humoral immune response, resulting in anergy and immunosuppression. In contrast, Staphylococcus epidermidis must rely primarily on cell-surface polymers and the ability to form a biolfilm to survive in the host.

3 Followers
 · 
136 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Postpartum Dysgalactia Syndrome (PDS) represents a considerable health problem of postpartum sows, primarily indicated by mastitis and lactation failure. The poorly understood etiology of this multifactorial disease necessitates the use of the porcine mammary epithelial cell (PMEC) model to identify how and to what extent molecular pathogen defense mechanisms prevent bacterial infections at the first cellular barrier of the gland. PMEC were isolated from three lactating sows and challenged with heat-inactivated potential mastitis-causing pathogens Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus) for 3 h and 24 h, in vitro. We focused on differential gene expression patterns of PMEC after pathogen challenge in comparison with the untreated control by performing microarray analysis. Our results show that a core innate immune response of PMEC is partly shared by E. coli and S. aureus. But E. coli infection induces much faster and stronger inflammatory response than S. aureus infection. An immediate and strong up-regulation of genes encoding cytokines (IL1A and IL8), chemokines (CCL2, CXCL1, CXCL2, CXCL3, and CXCL6) and cell adhesion molecules (VCAM1, ICAM1, and ITGB3) was explicitly obvious post-challenge with E. coli inducing a rapid recruitment and activation of cells of host defense mediated by IL1B and TNF signaling. In contrast, S. aureus infection rather induces the expression of genes encoding monooxygenases (CYP1A1, CYP3A4, and CYP1B1) initiating processes of detoxification and pathogen elimination. The results indicate that the course of PDS depends on the host recognition of different structural and pathogenic profiles first, which critically determines the extent and effectiveness of cellular immune defense after infection. Electronic supplementary material The online version of this article (doi:10.1186/s13567-015-0178-z) contains supplementary material, which is available to authorized users.
    Veterinary Research 05/2015; 46(1). DOI:10.1186/s13567-015-0178-z · 3.38 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Staphylococcus aureus represents one of the leading causes of mastitis in dairy cows worldwide. S. aureus IMI have variable outcomes due to virulence of the strain involved, immune defenses of the host, and by antibiotic resistance. The difficulty in eradication and the increasing concerns on antibiotics usages underscore the interest in developing new tools to control S. aureus mastitis. Vaccination represents one of the most studied of these tools but, so far, no vaccine seems to provide reliable protection. This review summarizes current knowledge on the major vaccine targets, including surface proteins, capsular polysaccharides, biofilm, and toxins. Finally, the present status of vaccination against S. aureus and the future of vaccine design were discussed, including how differences among in vivo models may influence vaccines development. Copyright © 2015 Elsevier Ltd. All rights reserved.
    Research in Veterinary Science 03/2015; DOI:10.1016/j.rvsc.2015.03.019 · 1.51 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Community-Acquired Methicillin-resistant S. aureus infections, generally occurring in previously healthy persons without recognizable risk factors for health care setting-related MRSA, are emerging as serious clinical and public health concerns. Community-Acquired Methicillin-resistant S. aureus, like all strains of S. aureus, is transmitted by direct contact with the organism. An overabundance of surface proteins and secreted virulence factors provide S. aureus with great potential to cause disease. Methicillin resistance is conferred by expression of the mecA gene, which encodes a modified penicillin-binding protein (PBP2a´hat has low affinity for β-lactam antibiotics and facilitates cell-wall synthesis in the presence of methicillin and other β-lactams. Geographically, there are two types of Community-Acquired Methicillin-resistant S. aureus: one (sequence type ST30) that is worldwide (pandemic) and the other (sequence types, ST1, ST8 or ST80) that is continent-specific. Panton-Valentine leukocidin (PVL) toxin, which is postulated to be at least partly responsible for the increased virulence of Community-Acquired Methicillin-resistant S. aureus compared to Health care Acquired Methicillin-resistant S. aureus. A latex agglutination test and nucleic acid amplification methods can be used to detect PBP2a and mecA gene. Incision and drainage continue to be the mainstay therapy for abscesses and furuncles. Patients with severe CA-MRSA infections require hospital admission and Vancomycin is still considered the first line treatment for severe infections. Standard infection control precautions should be used for all patients in outpatient and inpatient healthcare settings.

Preview

Download
2 Downloads
Available from